// App-Quantinova.ai

: EXTH-52. CO-TARGETING ONCOSTATIN M RECEPTOR USING MONOCLONAL ANTIBODIES IN COMBINATION WITH PRESENT STANDARDS OF CARE FOR GLIOBLASTOMA

Researchers

Presenter

  • Audrey Burban

Principal Investigators

  • Ahmad Sharanek

  • Arezu Jahani-Asl

Medical Centers

  • McGill University Lady Davis Institute for Medical Research, Montreal, Quebec, Canada

  • Montreal University, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Brain cancer

Biomarkers

  • Epidermal growth factor receptor

  • Immunoglobulin G

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • Temozolomide

  • L-Tyrosine

  • EGFRvIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved